Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases

Journal of Dermatological Science

Volumn 43, Issue 2, 2006, Pages 75-84

  Saeki, Hidehisa ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atopic dermatitis; Bullous pemphigoid; Mycosis fungoides; TARC CCL17

Indexed keywords

CHEMOKINE RECEPTOR CCR4; GAMMA INTERFERON; INTERLEUKIN 4; STEROID; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSFORMING GROWTH FACTOR ALPHA;

ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; BLISTER; CELL LINE; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE SEVERITY; DNA POLYMORPHISM; DOWN REGULATION; EVALUATION; HUMAN; JAPAN; KERATINOCYTE; LANGERHANS CELL; MEDICAL SOCIETY; MYCOSIS FUNGOIDES; NONHUMAN; PATHOGENESIS; PEMPHIGOID; PRIORITY JOURNAL; REVIEW; SERUM; SEZARY SYNDROME; SKIN DISEASE; T CELL LYMPHOMA; TH2 CELL;

CHEMOKINES, CC; DENDRITIC CELLS, FOLLICULAR; HUMANS; LYMPHOMA, T-CELL; SKIN DISEASES; SKIN NEOPLASMS; THYMUS GLAND;

EID: 33746199966     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.06.002     Document Type: Review

References (50)

1. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 (2000) 121-127
2. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol 2 (2001) 123-128
3. Sallusto F., Lenig D., Mackay C.R., et al. Flexible programs of chemokine receptors expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187 (1998) 875-883
4. Imai T., Yoshida T., Baba M., et al. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 271 (1996) 21514-21521
5. Sallusto F., Schaerli P., Loetscher P., et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28 (1998) 2760-2769
6. Campbell J.J., Haraldsen G., Pan J., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400 (1999) 776-780
7. Vestergaard C., Yoneyama H., Murai M., et al. Overexpression of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104 (1999) 1097-1105
8. Sekiya T., Miyamasu M., Imanishi M., et al. Inducible expression of a Th2-type CC chemokine thymus and activation-regulated chemokine by human bronchial epithelial cells. J Immunol 165 (2000) 2205-2213
9. Yu B., Koga T., Urabe K., et al. Differential regulation of thymus and activation-regulated chemokine induced by IL-4, IL-13, TNF-α and IFN-γ in human keratinocyte and fibroblast. J Dermatol Sci 30 (2002) 29-36
10. Nickel R., Beck L.A., Stellato C., et al. Chemokines and allergic diseases. J Allergy Clin Immunol 104 (1999) 723-742
11. Godisk R., Chantry D., Raport C.J., Sozzani S., Allavena P., Leviten D., et al. Human macrophage-derived chemokine (MDC) a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185 (1997) 1595-1604
12. Leung D.Y.M. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 105 (2000) 860-876
13. Hamid Q., Boguniewicz M., and Leung D.Y.M. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 94 (1994) 870-876
14. Furue M., Ohtsuki M., Ogata F., et al. Responsiveness to interleukin 4 and interleukin 2 of peripheral blood cells in atopic dermatitis. J Invest Dermatol 96 (1991) 468-472
15. Grewe M., Bruijnzeel-Koomen C.A.F.M., Schöpf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19 (1998) 359-361
16. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
17. Kakinuma T., Saeki H., Tsunemi Y., et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 111 (2003) 592-597
18. Shimada Y., Takehara K., and Sato S. Both Th2 and Th1 chemokines (TARC/CCL17 MDC/CCL22 and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 34 (2004) 201-208
19. + T cells reflect disease activity of atopic dermatitis. J Invest Dermatol 117 (2001) 188-196
20. Asbrink E., and Hovmark A. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies. Acta Derm Venereol 64 (1984) 243-246
21. Teraki Y., Hotta T., and Shiohara T. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol 117 (2001) 1097-1102
22. Kakinuma T., Wakugawa M., Nakamura K., et al. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid. Br J Dermatol 148 (2003) 203-210
23. Martin R.M., Estrach T., Reventer J.C., et al. Prognostic clinicopathologic factors in T-cell lymphoma. Arch Dermatol 127 (1991) 1511-1516
24. Zachariae C., Larsen C.S., Kaltoft K., et al. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders. Acta Derm Venereol 71 (1991) 465-470
25. Kakinuma T., Sugaya M., Nakamura K., et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: Serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48 (2003) 23-30
26. Ferenczi K., Fuhlbrigge R.C., Pinkus J.L., Pinkus G.S., and Kupper T.S. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119 (2002) 1405-1410
27. Tamaki K., Kakinuma T., Saeki H., et al. Serum levels of CCL17/TARC in various skin diseases. J Dermatol 33 (2006) 300-302
28. Nomiyama H., Imai T., Kusuda J., Miura R., Callen D.F., and Yoshie O. Human chemokine fractalkine (SCYD1), MDC (SCYA22) and TARC (SCYA17) are clustered on chromosome 16q13. Cytogenet Cell Genet 81 (1998) 10-11
29. Cookson W.O.C.M., Ubhi B., Lawrence R., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27 (2001) 372-373
30. Sekiya T., Yamada H., Yamaguchi M., et al. Increased levels of a Th-2 type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and sputum of asthmatics. Allergy 57 (2002) 173-177
31. Sekiya T., Tsunemi Y., Miyamasu M., et al. Variations in the human Th2-specific chemokine TARC gene. Immunogenetics 54 (2003) 742-745
32. Tsunemi Y., Komine M., Sekiya T., et al. The -431C > T polymorphism of thymus and activation-regulated chemokine increases the promoter activity but is not associated with susceptibility to atopic dermatitis in Japanese patients. Exp Dermatol 13 (2004) 715-719
33. + lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 115 (2000) 640-646
34. Zheng X., Nakamura K., Furukawa H., Nishibu A., Takahashi M., Tojo M., et al. Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis. J Dermatol 30 (2003) 26-32
35. Morita E., Hiragun T., Mihara S., Kaneko S., Matsuo H., Zhang Y., et al. Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 34 (2004) 237-240
36. Tsuda T., Tohyama M., Yamashita K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 31 (2003) 37-42
37. Kakinuma T., Nakamura K., Wakugawa M., Yano S., Saeki H., Torii H., et al. IL-4, but IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10 kDa)/CXCL10 release by TNF-α and IFN-γ in HaCaT cell line. Cytokine 20 (2002) 1-6
38. Vestergaard C., Kirstejn N., Gesser B., Mortensen J.T., Matsushima K., and Larsen C.G. IL-10 augments the IFN-γ and TNF-α induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis. J Dermatol Sci 26 (2001) 46-54
39. Zheng X., Nakamura K., Tojo M., et al. TGF-β1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-α and IFN-γ. J Dermatol Sci 30 (2002) 154-160
40. Sumiyashi K., Nakao A., Setoguchi Y., Tsuboi R., Okumura K., and Ogawa H. TGF-β/Smad signaling inhibits IFN-γ and TNF-α-induced TARC (CCL17) production in HaCaT cells. J Dermatol Sci 31 (2003) 53-58
41. Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., and Tamaki K. Mechanism of thymus and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 125 (2005) 491-498
42. Mascia F., Mariani V., Girolomoni G., and Pastore S. Blockade of the EGF receptor induces a degraded chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163 (2003) 303-312
43. Fujita H., Asahina A., Sugaya M., Nakamura K., Gao P., Fujiwara H., et al. Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells. J Invest Dermatol 124 (2005) 343-350
44. Salgado C.G., Nakamura K., Sugaya M., Tada Y., Asahina A., Koyama Y., et al. Functional CD40 ligand is expressed on epidermal Langerhans cells. J Leukocyte Biol 66 (1999) 281-285
45. Tada Y., Asahina A., Nakamura K., Tomura M., Fujisawa H., and Tamaki K. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. J Immunol 164 (2000) 5113-5119
46. Tada Y., Asahina A., Nakamura K., Miyazono K., Tomura M., Fujiwara H., et al. Transforming growth factor-β up-regulates CD40-engaged IL-12 production of mouse Langerhans cells. Eur J Immunol 31 (2001) 294-300
47. Tada Y., Asahina A., Fujita H., Sugaya M., and Tamaki K. Langerhans cells do not produce interferon-γ. J Invest Dermatol 120 (2003) 891-892
48. Mitsui H., Watanabe T., Saeki H., Mori K., Fujita H., Tada Y., et al. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J Invest Dermatol 122 (2004) 95-102
49. Fujita H., Asahina A., Mitsui H., and Tamaki K. Langerhans cells exhibit low responsiveness to double-stranded RNA. Biochem Biophys Res 319 (2004) 832-839
50. + T cells. Eur J Immunol 29 (1999) 2684-2694